Resuming GLP-1 Medications Post-Pregnancy: The timeline for resuming GLP-1 medications post-pregnancy is an intricate decision
potential long-term risks include pancreatitis, gallbladder disease, lean muscle loss, and early worsening of diabetic retinopathy, though no confirmed causal links exist beyond 48 weeks of data
Advances in our understanding of nutrient partitioning, protein synthesis, and metabolic regulation have challenged this dogma, and compounds like Retatrutide may make body recomposition practically achievable for a broader population
Mistake 3: taking a large meal right after injection Some researchers inject and then immediately eat a large meal, thinking the food will "buffer" nausea
This aligns with Retatrutides slowed gastric emptying and reduces the likelihood of feeling overly full or nauseated after eating
And both answers are coming from the clinical trial data were seeing right now